drugset / Trial / NCT01785472
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of multiple doses of LCZ696 compared to olmesartan in Asian patients with essential hypertension
Timeline
- Start
- 2013-04
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCZ696 | Unknown | 200 mg | — |
| Subject | LCZ696 | Unknown | 400 mg | — |
| Subject | Olmesartan | Other / unclassified | 20 mg | — |